COPD phenotypes not linked to increased risk of coronary heart disease

C. Svendsen (Bergen, Norway), T. Eagan (Bergen, Norway), P. Bakke (Bergen, Norway), R. Nielsen (Bergen, Norway), E. Nordeide (Bergen, Norway), V. Hodneland (Stord, Norway), K. Ostridge (Southampton, United Kingdom), T. Larsen (Bergen, Norway), K. Kuiper (Bergen, Norway)

Source: International Congress 2019 – Comorbidities galore in respiratory patients
Session: Comorbidities galore in respiratory patients
Session type: Oral Presentation
Number: 289
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Svendsen (Bergen, Norway), T. Eagan (Bergen, Norway), P. Bakke (Bergen, Norway), R. Nielsen (Bergen, Norway), E. Nordeide (Bergen, Norway), V. Hodneland (Stord, Norway), K. Ostridge (Southampton, United Kingdom), T. Larsen (Bergen, Norway), K. Kuiper (Bergen, Norway). COPD phenotypes not linked to increased risk of coronary heart disease. 289

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018



Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2002; 20: Suppl. 38, 247s
Year: 2002

OSA as a cause of cardiovascular disease, including heart failure
Source: ERS Conference
Year: 2015

Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018



Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Assessment of pulmonary function stratifies global coronary heart disease risk
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013


Increased risk of peripheral arterial disease in individuals with COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD)
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019


Genetically elevated ace activity is not associated with ischaemic heart disease, hypertension, or physical activity in COPD
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009


Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019

Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT)
Source: Eur Respir J 2007; 30: Suppl. 51, 122s
Year: 2007

Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 406s
Year: 2006

Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD)
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications
Source: International Congress 2015 – COPD: notable points
Year: 2015